Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy

J Yan, G Tie, TY Xu, K Cecchini, LM Messina - Stem Cell Reviews and …, 2013 - Springer
Mesenchymal stem cells (MSCs), due to their paracrine, transdifferentiation, and
immunosuppressive effects, hold great promise as a therapy for peripheral arterial disease …

Cell therapy in critical limb ischemia: current developments and future progress

MK Mamidi, R Pal, S Dey, BJJB Abdullah, Z Zakaria… - Cytotherapy, 2012 - Elsevier
Critical limb ischemia (CLI) is a syndrome manifested by ischemic rest pain, non-healing
ulcers and tissue loss. CLI patients are at very high risk of amputation and experience poor …

CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity

AM Burkhardt, KP Tai, JP Flores-Guiterrez… - The Journal of …, 2012 - journals.aai.org
The mucosal immune network is a crucial barrier preventing pathogens from entering the
body. The network of immune cells that mediates the defensive mechanisms in the mucosa …

The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions

V Saini, DM Staren, JJ Ziarek, ZN Nashaat… - Journal of Biological …, 2011 - ASBMB
Recently, we identified extracellular ubiquitin as an endogenous CXC chemokine receptor
(CXCR) 4 agonist. However, the receptor selectivity and molecular basis of the CXCR4 …

[HTML][HTML] RNA-seq based transcriptome analysis of endothelial differentiation of bone marrow mesenchymal stem cells

C Wang, H Liu, M Yang, Y Bai, H Ren, Y Zou… - European Journal of …, 2020 - Elsevier
Objective The aim was to identify the change in gene expression between mesenchymal
stem cells (MSCs) and induced endothelial cells (ECs) and to investigate the potential …

Autologous Bone Marrow Mononuclear Cell Implantation and Its Impact on the Outcome of Patients With Critical Limb Ischemia―Results of a Randomized, Double …

B Pignon, MA Sevestre, L Kanagaratnam… - Circulation …, 2017 - jstage.jst.go.jp
Background: Cell therapy is a therapeutic option for patients presenting with
nonrevascularizable critical limb ischemia (CLI). However there is a lack of firm evidence on …

Mesenchymal stem cells modified with angiopoietin-1 gene promote wound healing

Y Li, L Zheng, X Xu, L Song, Y Li, W Li, S Zhang… - Stem cell research & …, 2013 - Springer
Introduction Treatment of chronic skin wounds is difficult and largely ineffective. Little
improvement has been shown in promoting the healing of these wounds in the past few …

Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction

V Saini, A Marchese, WJ Tang, M Majetschak - Journal of Biological …, 2011 - ASBMB
Ubiquitin, a post-translational protein modifier inside the cell, functions as a CXC chemokine
receptor (CXCR) 4 agonist outside the cell. However, the structural determinants of the …

Stem cells in psoriasis

R Hou, J Li, X Niu, R Liu, W Chang, X Zhao… - Journal of …, 2017 - Elsevier
Psoriasis is a complex chronic relapsing inflammatory disease. Although the exact
mechanism remains unknown, it is commonly accepted that the development of psoriasis is …

Single-cell RNA sequencing reveals thoracolumbar vertebra heterogeneity and rib-genesis in pigs

J Li, L Wang, D Yu, J Hao, L Zhang… - Genomics …, 2021 - academic.oup.com
Abstract Development of thoracolumbar vertebra (TLV) and rib primordium (RP) is a
common evolutionary feature across vertebrates, although whole-organism analysis of the …